What Employers Need To Know About Trending Weight Loss Medications

In the past year, medications like Ozempic and Wegovy have gained national attention for their weight loss impacts. As the demand for these medications continues to surge, employers face a tough dilemma. The medications can have significant benefits for weight loss, and covering them could lead to direct and indirect savings on obesity-related health issues. Yet, they are costly and often are felt to be needed long term to maintain results. Today, only 22% of U.S. employers cover anti-obesity medication on their health plans.

When many employers are already grappling with the rising costs of healthcare driven by inflation, how should employers decide whether or not to cover weight loss medications?

In this on-demand webinar, Dr. Linda Anegawa, MD, MS, FACP, Chief of Medicine at Noom and award-winning, board-certified physician in Obesity Medicine and Internal Medicine, will share:

• Introduction to obesity as a chronic progressive disease needing specialized treatment.
• The current landscape of available weight loss medications, and future directions.
• Key considerations when evaluating coverage for weight loss medications.
• How employers can take a holistic approach to managing pre-obesity and obesity.